Listed

SELLAS Life Sciences Group, Inc.

SLSNasdaqCIK 1390478HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2023
Operating income−$10.6m, Q2 FY2026
Net income−$9.6m, Q2 FY2026
SELLAS Life Sciences Group, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2023-11-09, accession 0001390478-23-000024.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-28, accession 0001390478-24-000004. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Cost of revenue$m0.0Cost of revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-13, accession 0001390478-24-000021.Report this figure0.0Cost of revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-20, accession 0001390478-25-000003. Derived: 12-month figure less the 9-month figure.Report this figure0.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-13, accession 0001390478-25-000008.Report this figure0.0Cost of revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure0.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure0.0Cost of revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-19, accession 0001390478-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure0.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure0.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure0.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure0.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-19, accession 0001390478-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure0.0Cost of revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure0.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-11, accession 0001390478-26-000012. Derived: 6-month figure less the 3-month figure.Report this figure
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$m3.5Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$3.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-13, accession 0001390478-24-000021.Report this figure3.1Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$3.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-20, accession 0001390478-25-000003. Derived: 12-month figure less the 9-month figure.Report this figure4.5Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$4.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-13, accession 0001390478-25-000008.Report this figure2.4Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$2.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure3.0Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$3.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure2.5Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$2.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-19, accession 0001390478-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure2.9Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$2.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-13, accession 0001390478-25-000008.Report this figure3.0Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$3.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure2.9Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$2.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure3.5Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$3.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-19, accession 0001390478-26-000003. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Operating income$m(9.4)Operating income, Q3 FY2023, three months to 2023-09-30−$9.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001390478-24-000021.Report this figure(8.2)Operating income, Q4 FY2023, three months to 2023-12-31−$8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-20, accession 0001390478-25-000003. Derived: 12-month figure less the 9-month figure.Report this figure(9.6)Operating income, Q1 FY2024, three months to 2024-03-31−$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001390478-25-000008.Report this figure(7.6)Operating income, Q2 FY2024, three months to 2024-06-30−$7.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure(7.3)Operating income, Q3 FY2024, three months to 2024-09-30−$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure(6.9)Operating income, Q4 FY2024, three months to 2024-12-31−$6.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001390478-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(6.1)Operating income, Q1 FY2025, three months to 2025-03-31−$6.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure(6.9)Operating income, Q2 FY2025, three months to 2025-06-30−$6.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure(7.1)Operating income, Q3 FY2025, three months to 2025-09-30−$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure(8.3)Operating income, Q4 FY2025, three months to 2025-12-31−$8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001390478-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(9.3)Operating income, Q1 FY2026, three months to 2026-03-31−$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure(10.6)Operating income, Q2 FY2026, three months to 2026-06-30−$10.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(9.3)Net income, Q3 FY2023, three months to 2023-09-30−$9.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001390478-24-000021.Report this figure(8.1)Net income, Q4 FY2023, three months to 2023-12-31−$8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-20, accession 0001390478-25-000003. Derived: 12-month figure less the 9-month figure.Report this figure(9.6)Net income, Q1 FY2024, three months to 2024-03-31−$9.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-13, accession 0001390478-25-000008.Report this figure(7.5)Net income, Q2 FY2024, three months to 2024-06-30−$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure(7.1)Net income, Q3 FY2024, three months to 2024-09-30−$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure(6.7)Net income, Q4 FY2024, three months to 2024-12-31−$6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001390478-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(5.8)Net income, Q1 FY2025, three months to 2025-03-31−$5.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure(6.6)Net income, Q2 FY2025, three months to 2025-06-30−$6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure(6.8)Net income, Q3 FY2025, three months to 2025-09-30−$6.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure(7.7)Net income, Q4 FY2025, three months to 2025-12-31−$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001390478-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(8.4)Net income, Q1 FY2026, three months to 2026-03-31−$8.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure(9.6)Net income, Q2 FY2026, three months to 2026-06-30−$9.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure
Diluted EPS$ per share(0.33)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001390478-24-000021.Report this figurenot reported(0.21)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0001390478-25-000008.Report this figure(0.13)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure(0.10)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figurenot reported(0.07)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure(0.07)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure(0.06)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figurenot reported(0.05)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure(0.05)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure
Basic EPS$ per share(0.33)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001390478-24-000021.Report this figurenot reported(0.21)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001390478-25-000008.Report this figure(0.13)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure(0.10)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figurenot reported(0.07)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure(0.07)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure(0.06)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figurenot reported(0.05)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure(0.05)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure

Balance sheet

Cash and equivalents$138.3m, Q2 FY2026
Shareholders' equity$137.7m, Q2 FY2026
SELLAS Life Sciences Group, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m4.0Cash and equivalents, Q3 FY2023, at 2023-09-30$4.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001390478-23-000024.Report this figure2.5Cash and equivalents, FY2023, at 2023-12-31$2.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-20, accession 0001390478-25-000003.Report this figure18.4Cash and equivalents, Q1 FY2024, at 2024-03-31$18.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001390478-24-000010.Report this figure9.1Cash and equivalents, Q2 FY2024, at 2024-06-30$9.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001390478-24-000015.Report this figure21.0Cash and equivalents, Q3 FY2024, at 2024-09-30$21.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001390478-24-000021.Report this figure13.9Cash and equivalents, FY2024, at 2024-12-31$13.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-19, accession 0001390478-26-000003.Report this figure28.4Cash and equivalents, Q1 FY2025, at 2025-03-31$28.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001390478-25-000008.Report this figure25.3Cash and equivalents, Q2 FY2025, at 2025-06-30$25.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure44.3Cash and equivalents, Q3 FY2025, at 2025-09-30$44.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure71.8Cash and equivalents, FY2025, at 2025-12-31$71.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure107Cash and equivalents, Q1 FY2026, at 2026-03-31$107.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure138Cash and equivalents, Q2 FY2026, at 2026-06-30$138.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure
Current assets$m5.2Current assets, Q3 FY2023, at 2023-09-30$5.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001390478-23-000024.Report this figure3.2Current assets, FY2023, at 2023-12-31$3.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-20, accession 0001390478-25-000003.Report this figure21.5Current assets, Q1 FY2024, at 2024-03-31$21.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001390478-24-000010.Report this figure12.3Current assets, Q2 FY2024, at 2024-06-30$12.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001390478-24-000015.Report this figure24.0Current assets, Q3 FY2024, at 2024-09-30$24.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001390478-24-000021.Report this figure16.3Current assets, FY2024, at 2024-12-31$16.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0001390478-26-000003.Report this figure32.0Current assets, Q1 FY2025, at 2025-03-31$32.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001390478-25-000008.Report this figure29.4Current assets, Q2 FY2025, at 2025-06-30$29.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure49.1Current assets, Q3 FY2025, at 2025-09-30$49.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure75.2Current assets, FY2025, at 2025-12-31$75.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure111Current assets, Q1 FY2026, at 2026-03-31$111.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure143Current assets, Q2 FY2026, at 2026-06-30$142.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure
Total assets$m8.1Total assets, Q3 FY2023, at 2023-09-30$8.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001390478-23-000024.Report this figure6.2Total assets, FY2023, at 2023-12-31$6.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-20, accession 0001390478-25-000003.Report this figure24.4Total assets, Q1 FY2024, at 2024-03-31$24.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001390478-24-000010.Report this figure15.1Total assets, Q2 FY2024, at 2024-06-30$15.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001390478-24-000015.Report this figure26.5Total assets, Q3 FY2024, at 2024-09-30$26.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001390478-24-000021.Report this figure19.4Total assets, FY2024, at 2024-12-31$19.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-19, accession 0001390478-26-000003.Report this figure35.0Total assets, Q1 FY2025, at 2025-03-31$35.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001390478-25-000008.Report this figure32.3Total assets, Q2 FY2025, at 2025-06-30$32.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure51.6Total assets, Q3 FY2025, at 2025-09-30$51.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure78.3Total assets, FY2025, at 2025-12-31$78.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure114Total assets, Q1 FY2026, at 2026-03-31$114.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure145Total assets, Q2 FY2026, at 2026-06-30$145.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure
Current liabilities$m11.7Current liabilities, Q3 FY2023, at 2023-09-30$11.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001390478-23-000024.Report this figure13.7Current liabilities, FY2023, at 2023-12-31$13.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-20, accession 0001390478-25-000003.Report this figure14.4Current liabilities, Q1 FY2024, at 2024-03-31$14.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001390478-24-000010.Report this figure12.0Current liabilities, Q2 FY2024, at 2024-06-30$12.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001390478-24-000015.Report this figure10.6Current liabilities, Q3 FY2024, at 2024-09-30$10.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001390478-24-000021.Report this figure9.5Current liabilities, FY2024, at 2024-12-31$9.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-19, accession 0001390478-26-000003.Report this figure6.9Current liabilities, Q1 FY2025, at 2025-03-31$6.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001390478-25-000008.Report this figure6.0Current liabilities, Q2 FY2025, at 2025-06-30$6.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure5.9Current liabilities, Q3 FY2025, at 2025-09-30$5.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure7.0Current liabilities, FY2025, at 2025-12-31$7.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure6.5Current liabilities, Q1 FY2026, at 2026-03-31$6.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure7.6Current liabilities, Q2 FY2026, at 2026-06-30$7.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure
Total liabilities$m11.9Total liabilities, Q3 FY2023, at 2023-09-30$11.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001390478-23-000024.Report this figure14.2Total liabilities, FY2023, at 2023-12-31$14.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-20, accession 0001390478-25-000003.Report this figure14.8Total liabilities, Q1 FY2024, at 2024-03-31$14.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001390478-24-000010.Report this figure12.2Total liabilities, Q2 FY2024, at 2024-06-30$12.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001390478-24-000015.Report this figure10.6Total liabilities, Q3 FY2024, at 2024-09-30$10.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001390478-24-000021.Report this figure10.0Total liabilities, FY2024, at 2024-12-31$10.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-19, accession 0001390478-26-000003.Report this figure7.2Total liabilities, Q1 FY2025, at 2025-03-31$7.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001390478-25-000008.Report this figure6.2Total liabilities, Q2 FY2025, at 2025-06-30$6.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure5.9Total liabilities, Q3 FY2025, at 2025-09-30$5.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure7.5Total liabilities, FY2025, at 2025-12-31$7.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure6.8Total liabilities, Q1 FY2026, at 2026-03-31$6.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure7.7Total liabilities, Q2 FY2026, at 2026-06-30$7.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m(3.8)Shareholders' equity, Q3 FY2023, at 2023-09-30−$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001390478-24-000021.Report this figure(8.0)Shareholders' equity, FY2023, at 2023-12-31−$8.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-19, accession 0001390478-26-000003.Report this figure9.7Shareholders' equity, Q1 FY2024, at 2024-03-31$9.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure2.9Shareholders' equity, Q2 FY2024, at 2024-06-30$2.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure15.9Shareholders' equity, Q3 FY2024, at 2024-09-30$15.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure9.5Shareholders' equity, FY2024, at 2024-12-31$9.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure27.8Shareholders' equity, Q1 FY2025, at 2025-03-31$27.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure26.1Shareholders' equity, Q2 FY2025, at 2025-06-30$26.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure45.6Shareholders' equity, Q3 FY2025, at 2025-09-30$45.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure70.9Shareholders' equity, FY2025, at 2025-12-31$70.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure107Shareholders' equity, Q1 FY2026, at 2026-03-31$107.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure138Shareholders' equity, Q2 FY2026, at 2026-06-30$137.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure

Cash flow

Operating cash flow−$7.6m, Q2 FY2026
SELLAS Life Sciences Group, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(6.9)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$6.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001390478-24-000021. Derived: 9-month figure less the 6-month figure.Report this figure(4.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-20, accession 0001390478-25-000003. Derived: 12-month figure less the 9-month figure.Report this figure(10.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$10.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001390478-25-000008.Report this figure(9.7)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$9.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001390478-25-000016. Derived: 6-month figure less the 3-month figure.Report this figure(7.8)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$7.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001390478-25-000020. Derived: 9-month figure less the 6-month figure.Report this figure(7.2)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001390478-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(9.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$9.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure(7.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001390478-26-000012. Derived: 6-month figure less the 3-month figure.Report this figure(7.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$7.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001390478-25-000020. Derived: 9-month figure less the 6-month figure.Report this figure(4.9)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001390478-26-000003. Derived: 12-month figure less the 9-month figure.Report this figure(8.8)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$8.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure(7.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$7.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001390478-26-000012. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Dividends paid$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)189.18m, Q2 FY2026
SELLAS Life Sciences Group, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares20.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3020,562,351 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001390478-23-000024.Report this figure23.5Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3123,547,562 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001390478-24-000010.Report this figure28.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3028,347,920 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001390478-24-000015.Report this figure28.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3028,355,427 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001390478-24-000021.Report this figure44.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3144,812,996 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0001390478-25-000008.Report this figure57.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3057,630,506 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001390478-25-000016.Report this figure68.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3068,254,021 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure87.8Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3187,760,320 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure98.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3098,558,567 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure108Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30108,396,260 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001390478-25-000020.Report this figure172Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31172,481,541 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001390478-26-000008.Report this figure189Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30189,183,620 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure

Shares outstanding: 201.95mShares outstanding, period not labelled, at 2026-08-10201,945,709 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001390478-26-000012.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.